Laurel Hiatt

Mx. Laurel Hiatt

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BWBen Weisburd
Ben Weisburd
EDEgor Dolzhenko
Egor Dolzhenko
MBMark F. Bennett
Mark F. Bennett
MDMatt C. Danzi
Matt C. Danzi
IXIsaac R. L. Xu
Isaac R. L. Xu
FSFritz J. Sedlazeck
Fritz J. Sedlazeck
Tandem repeat (TR) catalogs are important components of repeat genotyping studies as they define the genomic coordinates and expected motifs of all TR loci being analyzed. In recent years, genome-wide studies have used catalogs ranging in size from fewer than 200,000 to over 7 million loci. Where these catalogs overlapped, they often disagreed on locus boundaries, hindering the comparison and reuse of results across studies. Now, with multiple groups developing public databases of TR variation in large population cohorts, there is a risk that, without sufficient consensus in the choice of locus definitions, the use of divergent repeat catalogs will lead to confusion, fragmentation, and incompatibility across resources. In this paper, we compare existing TR catalogs and discuss desirable features of a comprehensive genome-wide catalog. We then present a new, richly annotated catalog designed for large-scale analyses and population databases. This new catalog, which we call the TRExplorer catalog v1.0, contains 4.86 million TR loci and, unlike most catalogs, is designed to be useful for both short-read and long-read analyses. It consists of 4,803,366 STRs and 59,675 VNTRs, of which 780,607 STRs and 21,888 VNTRs are both polymorphic and entirely absent from widely-used catalogs previously developed for short-read analyses. Additionally, our catalog stratifies TRs into two groups: 1) isolated TRs suitable for repeat copy number analysis using short-read or long-read data and 2) so-called variation clusters that contain TRs within wider polymorphic regions that are best studied through sequence-level analysis. To define variation clusters, we present a novel algorithm that leverages long-read HiFi sequencing data to group repeats with surrounding polymorphisms. We show that the human genome contains at least 25,000 complex variation clusters, most of which span over 120 bp and contain five or more TRs. Resolving the sequence of entire variation clusters instead of individually genotyping constituent TRs leads to a more accurate analysis of these regions and enables us to profile variation that would have been missed otherwise. We also share the trexplorer.broadinstitute.org portal which allows anyone to search, visualize, and download the catalog along with variation clusters and annotations.

13 February 2025 in Genes
Verified
Journal Article
Open access
PDF file
RDRose M. Doss
Rose M. Doss
SLSusana M Lopez-Ignacio
Susana M Lopez-Ignacio
ADAnna Dischler
Anna Dischler
LHLaurel Hiatt
Laurel Hiatt
HDHarriet Dashnow
Harriet Dashnow
CDCaroline Dias
Caroline Dias
Fragile X, Huntington disease, and myotonic dystrophy type 1 are prototypical examples of human disorders caused by short tandem repeat variation, repetitive nucleotide stretches that are highly mutable both in the germline and somatic tissue. As short tandem repeats are unstable, they can expand, contract, and acquire and lose epigenetic marks in somatic tissue. This means within an individual, the genotype and epigenetic state at these loci can vary considerably from cell to cell. This somatic mosaicism may play a key role in clinical pathogenesis, and yet, our understanding of mosaicism in driving clinical phenotypes in short tandem repeat disorders is only just emerging. This review focuses on these three relatively well-studied examples where, given the advent of new technologies and bioinformatic approaches, a critical role for mosaicism is coming into focus both with respect to cellular physiology and clinical phenotypes.

19 May 2021 in SocArXiv
Verified
Preprint
Open access
CKClair Kronk
Clair Kronk
AEAvery R. Everhart
Avery R. Everhart
FAFlorence Ashley
Florence Ashley
HTHale Thompson
Hale Thompson
TSTheodore E. Schall
Theodore E. Schall
RKRyan Karnoski
Ryan Karnoski
There are over one million transgender people living in the United States and 33% report negative experiences with a healthcare provider, many of which are connected to data representation in electronic health records (EHRs). We present recommendations and common pitfalls involving sex- and gender-related data collection in EHRs. Our recommendations leverage the needs of patients, medical providers, and researchers to optimize both individual patient experiences and the efficacy and reproducibility of EHR population-based studies. We also briefly discuss adequate additions to the EHR considering name and pronoun usage. We add the disclaimer that these questions are more complex than commonly assumed. We conclude that collaborations between local transgender and gender-diverse persons and medical providers as well as open inclusion of transgender and gender-diverse individuals on terminology and standards boards is crucial to shifting the paradigm in transgender and gender-diverse health.

22 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
JKJason Kunisaki
Jason Kunisaki
MGMichael E. Goldberg
Michael E. Goldberg
SLSuchita Lulla
Suchita Lulla
TSThomas Sasani
Thomas Sasani
LHLaurel Hiatt
Laurel Hiatt
AQAaron R. Quinlan
Aaron R. Quinlan
Male infertility is associated with elevated rates of aneuploidy and DNA breaks in spermatozoa and germline precursors. This common condition is not well understood and is associated with poor individual and familial somatic health relative to fertile men. To further understand the extent and source of genome instability, we used error-corrected duplex DNA sequencing to test whether the impaired spermatogenesis and relatively poorer health of oligozoospermic men are linked to elevated single nucleotide de novo mutation frequencies in their sperm and blood, respectively. We observed a significant 1.34 to 2.01-fold increase in age-adjusted sperm mutation frequencies in infertile, oligozoospermic men. Conversely, consistently elevated mutation frequencies in the blood of oligozoospermic men were not found. Gain-of-function mutations linked to clonal spermatogenesis and Mendelian disorders accumulate with age at a similar rate in normozoospermic and oligozoospermic men. These results implicate germline hypermutation as a hallmark feature of oligozoospermia and point to age-independent processes affecting spermatogonial stem cell biology that may underlie spermatogenic impairment before and after puberty. Our findings also underscore the importance of investigating tissue-specific mechanisms driving the association between reduced reproductive and somatic health in infertile men.

21 May 2024 in medRxiv
Verified
Preprint
Open access
PDF file
LHLaurel Hiatt
Laurel Hiatt
BWBen Weisburd
Ben Weisburd
EDEgor Dolzhenko
Egor Dolzhenko
GVGrace E. VanNoy
Grace E. VanNoy
EKEdibe Nehir Kurtas
Edibe Nehir Kurtas
HDHarriet Dashnow
Harriet Dashnow
Approximately 3% of the human genome consists of repetitive elements called tandem repeats (TRs), which include short tandem repeats (STRs) of 1–6bp motifs and variable number tandem repeats (VNTRs) of 7+bp motifs. TR variants contribute to several dozen mono- and polygenic diseases but remain understudied and “enigmatic,” particularly relative to single nucleotide variants. It remains comparatively challenging to interpret the clinical significance of TR variants. Although existing resources provide portions of necessary data for interpretation at disease-associated loci, it is currently difficult or impossible to efficiently invoke the additional details critical to proper interpretation, such as motif pathogenicity, disease penetrance, and age of onset distributions. It is also often unclear how to apply population information to analyses. We present STRchive (S-T-archive, http://strchive.org/ ), a dynamic resource consolidating information on TR disease loci in humans from research literature, up-to-date clinical resources, and large-scale genomic databases, with the goal of streamlining TR variant interpretation at disease-associated loci. We apply STRchive —including pathogenic thresholds, motif classification, and clinical phenotypes—to a gnomAD cohort of ∼18.5k individuals genotyped at 60 disease-associated loci. Through detailed literature curation, we demonstrate that the majority of TR diseases affect children despite being thought of as adult diseases. Additionally, we show that pathogenic genotypes can be found within gnomAD which do not necessarily overlap with known disease prevalence, and leverage STRchive to interpret locus-specific findings therein. We apply a diagnostic blueprint empowered by STRchive to relevant clinical vignettes, highlighting possible pitfalls in TR variant interpretation. As a living resource, STRchive is maintained by experts, takes community contributions, and will evolve as understanding of TR diseases progresses.

20 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
HDHarriet Dashnow
Harriet Dashnow
BPBrent S. Pedersen
Brent S. Pedersen
LHLaurel Hiatt
Laurel Hiatt
JBJoe Brown
Joe Brown
SBSarah J. Beecroft
Sarah J. Beecroft
AQAaron R. Quinlan
Aaron R. Quinlan
Expansions of short tandem repeats (STRs) cause dozens of rare Mendelian diseases. However, STR expansions, especially those arising from repeats not present in the reference genome, are challenging to detect from short-read sequencing data. Such “novel” STRs include new repeat units occurring at known STR loci, or entirely new STR loci where the sequence is absent from the reference genome. A primary cause of difficulty detecting STR expansions is that reads arising from STR expansions are frequently mismapped or unmapped. To address this challenge, we have developed STRling, a new STR detection algorithm that counts k-mers (short DNA sequences of length k) in DNA sequencing reads, to efficiently recover reads that inform the presence and size of STR expansions. As a result, STRling can call expansions at both known and novel STR loci. STRling has a sensitivity of 83% for 14 known STR disease loci, including the novel STRs that cause CANVAS and DBQD2. It is the first method to resolve the position of novel STR expansions to base pair accuracy. Such accuracy is essential to interpreting the consequence of each expansion. STRling has an estimated 0.078 false discovery rate for known pathogenic loci in unaffected individuals and a 0.20 false discovery rate for genome-wide loci in unaffected individuals when using variants called from long-read data as truth. STRling is fast, scalable on cloud computing, open-source, and freely available at https://github.com/quinlan-lab/STRling .